Ketamine modulates TRH and TRH-like peptide turnover in brain and peripheral tissues of male rats

Peptides

Volumn 69, Issue , 2015, Pages 66-76

  Pekary, A Eugene ^a,b   Sattin, Albert ^a   Lloyd, Robert L ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MINNESOTA DULUTH   (United States)

Author keywords

Anxiety; Depression; Limbic system; Neuroendocrine

Indexed keywords

GLUTAMIC ACID; KETAMINE; PROTIRELIN; SODIUM CHLORIDE; N METHYLASPARTIC ACID; PEPTIDE;

ADRENAL GLAND; AMYGDALOID NUCLEUS; ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTERIOR CINGULATE; AREA UNDER THE CURVE; ARTICLE; BIOSYNTHESIS; BRAIN LEVEL; BRAIN TISSUE; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; ENTORHINAL CORTEX; EPIDIDYMIS; FRONTAL CORTEX; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; HORMONE BLOOD LEVEL; HYPOTHALAMUS; MALE; MEDULLA OBLONGATA; NONHUMAN; NUCLEUS ACCUMBENS; PANCREAS; POSTERIOR CINGULATE; PRIORITY JOURNAL; PROSTATE; PYRIFORM CORTEX; RAT; TESTIS; ANIMAL; ANTAGONISTS AND INHIBITORS; BRAIN; DEPRESSIVE DISORDER, MAJOR; DRUG EFFECTS; HUMAN; METABOLISM; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT; SUICIDE;

RATTUS;

ANIMALS; BRAIN; DEPRESSIVE DISORDER, MAJOR; HUMANS; KETAMINE; MALE; N-METHYLASPARTATE; PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; SUICIDE; THYROTROPIN-RELEASING HORMONE;

EID: 84928384003     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2015.04.003     Document Type: Article

References (72)

1. M. Arnold, and W. Langhan Effects of anesthesia and blood sampling techniques on plasma metabolites and corticosterone in the rat Physiol Behav 99 2010 592 598
2. A.E. Autry, M. Adachi, E. Nosyreva, E.S. Na, M.F. Los, and P-F. Cheng NMDA receptor blockade at rest triggers rapid behavioral antidepressant responses Nature 475 2011 91 97
3. E.D. Ballard, D.F. Ionescu, J.L. Vande Voort, M.J. Niciu, E.M. Richards, and D.A. Luckenbaugh Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxiety J Psychiatr Res 58 2014 161 166
4. I. Bojak, H.C. Day, and D.T.J. Liley Ketamine, propofol, and the EEG: a neural field analysis of HCN1-mediated interactions Front Comput Neurosci 2013 DOI 3389/fncom.2013.00022
5. A.H. Bowker, and G.J. Lieberman Engineering statistics 1959 Prentice-Hall, Inc. Englewood Cliffs, N.J.
6. A.M. Callahan, M.A. Frye, L.B. Marangell, M.S. George, T.A. Ketter, and T. L'Herrou Comparative antidepressant effects of parenteral and intrathecal thyrotropin releasing hormone: confounding effects of tolerance and implications for therapeutics Biol Psychiatr 41 1997 264 272
7. E. Check Comfortably numb Nature 443 2006 629 631
8. O. Darbin, J.J. Risso, E. Carre, M. Lonjon, and D. Naritoku Striatal energetic homeostasis under anaesthetic conditions Brain Res 1388 2011 157 166
9. L. De Oliveira, D.B. Fraga, R.D. De Luca, L. Canever, F.V. Ghedim, and M.P. Matos Behavioral changes and mitochondrial dysfunction in a rat model of schizophrenia induced by ketamine Metab Brain Dis 26 2011 69 77
10. F. Derakhshan, and C. Toth Insulin and the brain Curr Diabetes Rev 9 2013 2 16
11. N. DiazGranados, L.A. Ibrahim, N.E. Brutsche, R. Ameli, I.D. Henter, and D.A. Luchenbaugh Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder J Clin Psychiatr 71 2010 1605 1611
12. R.S. Duman, N. Li, R.J. Liu, V. Duric, and G. Aghajanian Signaling pathways underlying the rapid antidepressant actions of ketamine Neuropharmacology 62 2012 35 41
13. R.S. Duman, and B. Voleti Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents Trends Neurosci 35 2012 47 56
14. C. Eintrei, L. Sokoloff, and C.B. Smith Effects of diazepam and ketamine administered individually or in combination on regional rates of glucose utilization in rat brain Br J Anaest 82 1999 596 602
15. W.H. Frey 2nd Intranasal insulin to treat and protect against posttraumatic stress disorder J Nerv Ment Dis 201 2013 638 639
16. M. Gutierrez-Mariscal, P. de Gortari, C. Lopez-Rubalcava, A. Martinez, and P. Joseph-Bravo Analysis of the anxiolytic-like effect of TRH and the response of amygdalar TRHergic neurons in anxiety Psychoneuroendocrinology 33 2008 198 213
17. D.A. Haas, and D.G. Harper Ketamine: a review of its pharmacologic properties and use in ambulatory anesthesia Anesth Prog 39 1992 61 68
18. F.E. Harrison, and J.M. May Vitamin C function in the brain: vital role of the ascorbate transporter (SVCT2) Free Radic Biol Med 45 2009 719 730
19. R.M. Hirschfeld Epidemiology of depression and evolution of treatment J Clin Psychiatr 73 Suppl. 1 2012 5 9
20. S. Houy, P. Croise, O. Gubar, S. Chasserot-Golaz, P. Tryoen-Toth, and Y. Bailly Exocytosis and endocytosis in neuroendocrine cells: Inseparable membranes! Front Endocrinol 4 2013 135
21. L. Ibrahim, N. DiazGranados, D.A. Luckenbaugh, R. Machado-Vieira, J. Baumann, and A.G. Mallinger Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression Prog Neuropsychopharmacol Biol Psychiatr 35 2011 1155 1159
22. D.F. Ionescu, D.A. Luckenbaugh, M.J. Niciu, E.M. Richards, E.E. Slonena, and J.L. Vande Voort Effect of baseline anxious depression on initial and sustained antidepressant response to ketamine J Clin Psychiatr 75 2014 e932 e938
23. S.A. Irwin, A. Iglewicz, R.A. Nelesen, L. JY, C.H. Carr, and S.D. Romero Daily oral ketamine for the treatment of depression and anxiety in patients receiving hospice care: a 28-day open-label proof-of-concept trial J Palliative Med 16 2013 958 965
24. M. Jenstad, and F.A. Chaudhry The amino acid transporters of the glutamate/GABA-glutamine cycle and their impact on insulin and glucagon secretion Front Endocrinol 2013 10.3389/fendo.2013.00199
25. J.A. Kelly, G.R. Slator, K.F. Tipton, C.H. Williams, and K. Bauer Kinetic investigation of the specificity of porcine brain thyrotropin-releasing hormone-degrading ectoenzyme for thyrotropin-releasing hormone-like peptides J Biol Chem 275 2000 16746 16751
26. N. Li, R.J. Liu, J.M. Dwyer, M. Banasr, B. Lee, and H. Son Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic deficits caused by chronic stress exposure Biol Psychiatr 69 2011 754 761
27. R.L. Lloyd, A. Harrison, A.E. Pekary, and A. Sattin Antidepressant efficacy of a nasally administered analog of thyrotropin-releasing hormone, EEP Society for neuroscience, 35th annual meeting Washington, DC, Nov. 12-16, 2005 2005 Abst. 447.11
28. R.L. Lloyd, A.E. Pekary, A. Sattin, and T. Amundson Antidepressant effects of Thyrotropin-releasing hormone analogues using a rodent model of depression Pharmacol Biochem Behav 70 2001 15 22
29. J.P. Lowry, and M. Fillenz Real-time monitoring of brain energy metabolism in vivo using microelectrochemical sensors: the effects of anesthesia Bioelectrochemistry 54 2001 39 47
30. R. Machado-Vieira, G. Salvadore, N. DiazGranados, and C.A. Zarate Jr. Ketamine and the next generation of antidepressants with a rapid onset of action Pharmacol Ther 123 2009 143 150
31. S. Maeng, and C.A. Zarate Jr. The role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects Curr Psychiatr Rep 9 2007 467 474
32. L.B. Marangell, M.S. George, A.M. Callahan, T.A. Ketter, P.J. Pazzaglia, and T.A. L'Herrou Effects of intrathecal thyrotropin-releasing hormone (protirelin) in refractory depressed patients Arch Gen Psychiatr 54 1997 214 222
33. J.M. May, Z.-C. Qu, R. Nazarewicz, and S. Kikalov Ascoric acid efficiently enhances neuronal synthesis of norepinephrine from dopamine Brain Res Bull 90 2013 35 42
34. B. Moghaddam, B. Adams, A. Verma, and D. Daly Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex J Neurosci 17 1997 2921 2927
35. J.W. Murrough Ketamine as a novel antidepressant: from synapse to behavior Clin Pharmacol Ther 91 2012 303 330
36. J.W. Murrough, and D.S. Charney Is there anything really novel on the antidepressant horizon Curr Psychiatr Rep 14 2012 643 649
37. J.W. Murrough, D.V. Iosifescu, L.C. Chang, R.K. Al Jurdi, C.E. Green, and A.M. Perez Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial Am J Psychiatr 170 2013 1134 1142
38. R.T. Owen Glutamatergic approaches in major depressive disorder: focus on ketamine, memantine and riluzole Drugs Today 48 2012 469 478
39. T. Palenicek, M. Fujakova, M. Brunovsky, M. Balikova, J. Horacek, and I. Goorman Electroencephalographic spectral and coherence analysis of ketamine in rats: correlation with behavioral effects and pharmacokinetics Neuropsychobiology 63 2011 202 218
40. D.F. Papolos, M.H. Teicher, G.L. Faedda, P. Murphy, and S. Mattis Clinical experience using intranasal ketamine in the treatment of pediatric bipolar disorder/fear of harm phenotype J Affect Disorder 147 2013 431 443
41. A.E. Pekary Chapter 126. TRH A.J. Kastin, The handbook of biologically active peptides 2nd ed. 2013 Elsevier Inc. Waltham 951 956
42. A.E. Pekary, K.F. Faull, M. Paulson, R.L. Lloyd, and A. Sattin TRH-like antidepressant peptide, pyroglutamyltyrosylprolineamide, occurs in rat brain J Mass Spectrom 40 2005 1232 1236
43. A.E. Pekary, and A. Sattin Rapid stimulation of TRH and TRH-like peptide release in rat brain and peripheral tissues by Ghrelin and 3-Trp-Ghrelin Peptides 36 2012 157 167
44. A.E. Pekary, and A. Sattin Increased TRH and TRH-like peptide release in rat brain and peripheral tissues during proestrus/estrus Peptides 52 2014 1 10
45. A.E. Pekary, A. Sattin, and J. Blood Rapid modulation of TRH and TRH-like peptide release in rat brain and peripheral tissues by leptin Brain Res 1345 2010 9 18
46. A.E. Pekary, A. Sattin, and J.D. Blood TRH and TRH-like peptide expression in rat following episodic or continuous corticosterone Psychoneuroendocrinology 33 2008 1183 1197
47. A.E. Pekary, A. Sattin, and R.L. Lloyd Electroconvulsive seizures increase levels of pGlu-Glu-Pro-NH2 (EEP) in rat brain Peptides 20 1999 107 119
48. A.E. Pekary, A. Sattin, J.L. Meyerhoff, and M. Chilingar Valproate moderates TRH receptor, TRH and TRH-like peptide levels in rat brain Peptides 25 2004 647 658
49. A.E. Pekary, A. Sattin, and S.A. Stevens Rapid modulation of TRH-like peptide levels in rat brain by thyroid hormones Peptides 27 2006 1577 1588
50. A.E. Pekary, R. Stephens, M. Simard, X-P. Pang, V. Smith, and J.J. DiStefano III Release of thyrotropin and prolactin by a Thyrotropin-releasing hormone (TRH) precursor, TRH-Gly: conversion to TRH is sufficient for in vivo effects Neuroendocrinology 52 1990 618 625
51. A.E. Pekary, S.A. Stevens, J.D. Blood, and A. Sattin Rapid modulation of TRH and TRH-like peptide release in rat brain, pancreas, and testis by a GSK-3β inhibitor Peptides 31 2010 1083 1093
52. A.E. Pekary, A.S. Stevens, and A. Sattin Rapid modulation of TRH and TRH-like peptide levels in rat brain and peripheral tissues by corticosterone Neurochem Int 48 2006 208 217
53. A.E. Pekary, S.A. Stevens, and A. Sattin Valproate and copper accelerate TRH-like peptide synthesis in rat pancreas and reproductive tissues Peptides 27 2006 2901 2911
54. A.E. Pekary, S.A. Stevens, and A. Sattin Circadian rhythms of TRH-like peptide levels in rat brain Brain Res 1125 2006 67 76
55. A.E. Pekary, S.A. Stevens, and A. Sattin Lipopolysaccharide modulation of TRH and TRH-like peptide levels in rat brain and endocrine organs J Mol Neurosci 31 2007 245 259
56. C.A. Porro, M. Cavazzuti, D. Giuliani, V. Vellani, F. Lui, and P. Baraldi Effects of ketamine anesthesia on central nociceptive processing in the rat: a 2-deoxyglucose study Neuroscience 125 2004 485 494
57. M.A. Reger, G.S. Watson, P.S. Green, L.D. Baker, B. Cholerton, and M.A. Fishel Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-β in memory-impaired older adults J Alzheimer's Dis 13 2008 323 331
58. W.M.S. Russell, and R.L. Burch The principles of humane experimental technique 1959 Methuen and Co London
59. J.K. Saha, J. Xia, J.M. Grondin, S.K. Engle, and J.A. Jabubowski Acute hyperglycemia induced by ketamine/xylazine anesthesia in rats: mechanisms and implications for preclinical models Exp Biol Med 230 2005 777 784
60. G. Salvadore, B.R. Cornwell, V. Colon-Rosario, R. Coppola, C. Grillon, and C.A. Zarate Jr. Increased anterior cingulate cortical activity in response to fearful faces: a neurophysiological biomarker that predicts rapid antidepressant response to ketamine Biol Psychiatr 65 2009 289 295
61. G. Salvadore, B.R. Cornwell, F. Sambataro, D. Latov, V. Colon-Rosario, and F. Carver Anterior cingulate desynchronization and functional connectivity with the amygdala during a working memory task predict rapid antidepressant response to ketamine Neuropsychopharmacology 35 2010 1415 1422
62. A. Sattin The role of TRH and related peptides in the mechanism of action of ECT J ECT 15 1999 76 92
63. A. Sattin, A.E. Pekary, and J.D. Blood Rapid modulation of TRH and TRH-like peptide release in rat brain and peripheral tissues by prazosin Peptides 32 2011 1666 1676
64. A. Sattin, A.E. Pekary, and J. Blood Escitalopram regulates expression of TRH and TRH-like peptides in rat brain and peripheral tissues Neuroendocrinology 88 2008 135 146
65. C.C. Sigueira, R.R. Rossoni, and L.C. Schenberg Dorsal periaqueductal gray matter-evoked panic-like behaviors are markedly inhibited by a low peripheral dose of thyrotropin releasing hormone Psychoneuroendocrinology 35 2010 262 271
66. K.J. Sufka, and S.W. White Identification of a treatment-resistant, ketamine-sensitive genetic line in the chick anxiety-depression model Pharmacol Biochem Behav 113 2013 63 67
67. M.C. Veronesi, D.J. Kubek, and M.J. Kubek Intranasal delivery of neuropeptides Methods Mol Biol 789 2011 303 312
68. A.A. Walf, and C.A. Frye The use of the elevated plus maze as an assay of anxiety-related behavior in rodents Nat Protocols 2 2007 322 328
69. J.R. Werther Ketamine anesthesia Anesth Prog 32 1985 185 188
70. D. Wheeler, M.G. Boutelle, and M. Fillenz The role of N-methyl-D-aspartate receptors in the regulation of physiologically released dopamine Neuroscience 65 1995 767 774
71. C.A. Zarate Jr., N.E. Brutsche, L. Ibrahim, J. Franco-Chaves, N. DiazGranados, and A. Cravchik Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial Biol Psychiatr 71 2013 939 946
72. C.A. Zarate Jr., D.C. Mathews, and M.L. Furey Human biomarkers of rapid antidepressant effects Biol Psychiatr 73 2013 1142 1155